The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats

European Journal of Pharmacology

Volumn 650, Issue 2-3, 2011, Pages 703-707

  Duttaroy, Alokesh ^a   Voelker, Frank ^a   Merriam, Kimberley ^a   Zhang, Xia ^a   Ren, Xianglin ^a   Subramanian, Kala ^a   Hughes, Thomas E ^a   Burkey, Bryan F ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Apoptosis; Beta cell mass; DPP 4; Glucagon like peptide 1; Pancreatic insulin content; Replication; Vildagliptin

Indexed keywords

GLUCOSE; INSULIN; PLACEBO; VILDAGLIPTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIVISION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ADAMANTANE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; INSULIN-SECRETING CELLS; NITRILES; PYRROLIDINES; RATS; RATS, WISTAR;

EID: 78651101398     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.062     Document Type: Article

References (24)

1. B. Ahren, and T.E. Hughes Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice Endocrinol. 146 2005 2055 2059
2. B. Ahren, R. Gomis, E. Standl, D. Mills, and A. Schweizer Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes Diab. Care 27 2004 2874 2880
3. B. Ahren, M.S. Winzell, B. Burkey, and T.E. Hughes Beta-cell expression of a dominant-negative HNF-1α comprises the ability of inhibition of dipeptidyl dipeptidase-4 to elicit a long-term augmentation of insulin secretion in mice Eur. J. Pharmacol. 521 2005 1164 1168
4. M. Banerjee, N. Younis, and H. Sran Vildagliptin in clinical practice: a review of literature Expert Opin. Pharmacother. 10 2009 2745 2757
5. Bonner-Weir S. β-Cell turnover; its assessment and implications Diabetes 50 Suppl I 2001 S20 S24
6. P.L. Brubaker, and D.J. Drucker Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system Endocrinol. 145 2004 2653 2659
7. B.F. Burkey, X. Li, L. Bolognese, B. Balkan, M. Mone, M. Russell, T.E. Hughes, and P.R. Wang Acute and chronic effects of the incretin enhancer vildaglitpin in insulin resistant rats J. Pharmacol. Exp. Ther. 315 2005 688 695
8. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, and P.C. Butler β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes Diabetes 52 2003 102 110
9. S.L. Conarello, Z. Li, J. Ronan, R.S. Roy, L. Zhu, G. Jiang, F. Liu, J. Woods, E. Zycband, D.E. Moller, N.A. Thornberry, and B.B. Zhang Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance Proc. Natl Acad. Sci. USA 100 2003 6825 6830
10. J.M. Egan, A. Bulotta, H. Hui, and R. Perfetti GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells Diab. Metab. Res. Rev. 19 2003 115 123
11. J.J. Holst, and C.F. Deacon Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus Curr. Opin. Pharmacol. 4 2004 589 596
12. Y. Li, T. Hansotia, B. Yusta, F. Ris, P.A. Halban, and D.J. Drucker Glucagon-like peptide-1 receptor signaling modulates β-cell apoptosis J. Biol. Chem. 278 2003 471 478
13. J.F. List, and J.F. Habener Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells Am. J. Physiol. Endocrinol. Metab. 286 2004 E875 E881
14. A. Maida, T. Hansotia, C. Longuet, Y. Seino, and D.J. Drucker Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice Gastroenterology 137 2009 2146 2157
15. J. Mu, J. Woods, Y.P. Zhou, R.S. Roy, Z. Li, E. Zycaband, Y. Feng, L. Zhu, C. Li, A.D. Howard, D.E. Moller, N.A. Thornberry, and B.B. Zhang Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes Diabetes 55 2006 1695 1704
16. J. Mu, A. Petrov, G.J. Eiermann, J. Woods, Y.P. Zyou, Z. Li, E. Zycaband, Y. Feng, L. Zhu, R.S. Roy, A.D. Howard, C. Li, N.A. Thornberry, and B.B. Zhang Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes Eur. J. Pharmacol. 623 2009 148 154
17. J.A. Pospisilik, J. Martin, T. Doty, J.A. Ehses, N. Pamir, F.C. Lynn, S. Piteau, H.U. Demuth, C.H. McIntosh, and R.A. Pederson Dipeptidyl peptidase IV inhibitor treatment stimulates β-cell survival and islet neogenesis in streptozotocin-induced diabetic rats Diabetes 52 2003 741 750
18. L. Scaglia, S. Smith, and S. Bonner-Weir Apoptosis contributes to the involution of β cell mass in the post partum rat pancreas Endocrinol. 136 1995 5461 5468
19. L. Scaglia, C.J. Cahill, D.T. Fiengood, and S. Bonner-Weir Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat Endocrinol. 138 1997 1736 1741
20. D.A. Stoffers The development of beta-cell mass: recent progress and potential role of GLP-1 Horm. Metab. Res. 36 2004 811 821
21. A. Trumper, K. Trumper, and D. Horsch Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells J. Endocrinol. 174 2002 233 246
22. E.B. Villhauer, J.A. Brinkman, G.B. Naderi, B.F. Burkey, B.E. Dunning, K. Prasad, B.L. Mangold, M.E. Russell, and T.E. Hughes 1-[[(3-hydroxy-1-adamantyl) amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties J. Med. Chem. 46 2003 2774 2789
23. G. Xu, D.A. Stoffers, J.F. Habener, and S. Bonner-Weir Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats Diabetes 48 1999 2270 2276
24. K. Yamamoto, H. Hashimoto, S. Tomimoto, N. Shintani, J. Miyazaki, F. Tashiro, H. Aihara, T. Nammo, M. Li, K. Yamagata, J. Miyagawa, Y. Matsuzawa, Y. Kawabata, Y. Fukuyama, K. Koga, W. Mori, K. Tanaka, T. Matsuda, and A. Baba Overexpression of PACAP in transgenic mouse pancreatic beta-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes Diabetes 52 2003 1155 1162